ANGEL MORAN
SACRAMENTO, CA NPI 1629435896
Browse related groups: CA Daiichi Sankyo Inc. All categories
General Payments — all program years on this page
$2,511.09
- Category: General Payments
- Program years: PY2022–2024
- Record count: 123
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,146.45 across 54 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,146.45 | 54 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $181.05 | 10 |
| Janssen Biotech, Inc. | $132.26 | 7 |
| Lilly USA, LLC | $107.79 | 5 |
| GlaxoSmithKline, LLC. | $80.57 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $79.08 | 4 |
| SOBI, INC | $72.92 | 3 |
| Astellas Pharma US Inc | $70.91 | 3 |
| Siemens Medical Solutions USA, Inc. | $60.18 | 2 |
| PFIZER INC. | $59.14 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.58 | 2 |
| Incyte Corporation | $37.08 | 2 |
| Agios Pharmaceuticals, Inc. | $35.29 | 2 |
| Myriad Genetic Laboratories, Inc. | $24.59 | 1 |
| Genentech USA, Inc. | $24.56 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $24.23 | 1 |
| EISAI INC. | $22.32 | 1 |
| E.R. Squibb & Sons, L.L.C. | $21.90 | 1 |
| Deciphera Pharmaceuticals Inc. | $19.81 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.36 | 1 |
| ABBVIE INC. | $16.71 | 1 |
| Blueprint Medicines Corporation | $14.12 | 1 |
By program year
Records — PY2024 (54)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.